Tuesday - June 9, 2026
Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML
June 03, 2026
BUFFALO, New York, June 3 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:

* * *

Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML

*

BUFFALO, N.Y. -New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational treatment approach using the targeted therapy ziftomenib for patients with a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products